Inactive Instrument
Abpro Corporation Stock Nasdaq
Stocks
US0008501076
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 2.36M 2.1M 1.95M 1.76M 3.32M 223M 3.36M 23.36M 9.17M 117M 8.86M 8.67M 373M | P/E 2024 |
-2.41x | P/E 2025 | -3.27x |
|---|---|---|---|---|---|
| Enterprise Value | 2.44M 2.18M 2.01M 1.82M 3.43M 230M 3.47M 24.15M 9.48M 121M 9.16M 8.97M 386M | EV / Sales 2024 |
497x | EV / Sales 2025 | - |
| Free-Float |
83.91% | Yield 2024 * |
-
| Yield 2025 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.36M | |
| -0.21% | -4.43% | +44.40% | +74.13% | 66.22B | |
| -2.80% | +0.13% | +7.11% | +68.46% | 55.2B | |
| +0.05% | +3.97% | +12.11% | +91.64% | 52.79B | |
| +3.28% | +5.58% | +26.51% | +50.05% | 45.53B | |
| +0.51% | +9.95% | +22.40% | +133.92% | 43.94B | |
| -1.15% | +0.39% | +263.21% | +594.60% | 41.64B | |
| +0.10% | +9.90% | +16.11% | +59.33% | 34B | |
| -8.66% | -7.32% | +25.85% | -2.32% | 25.84B | |
| -0.76% | +2.81% | +35.42% | +25.42% | 23.51B | |
| Average | -1.01% | +4.07% | +50.35% | +121.69% | 43.19B | |
| Weighted average by Cap. | -0.78% | +3.72% | +49.33% | +126.08% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 183K 163K 151K 137K 257K 17.27M 260K 1.81M 710K 9.08M 686K 672K 28.93M | - |
| Net income | -7.23M -6.44M -5.97M -5.4M -10.17M -682M -10.29M -71.54M -28.07M -359M -27.13M -26.56M -1.14B | -2.89M -2.58M -2.39M -2.16M -4.07M -273M -4.12M -28.61M -11.22M -143M -10.85M -10.62M -457M |
| Net Debt | 478K 426K 394K 357K 672K 45.11M 680K 4.73M 1.86M 23.71M 1.79M 1.76M 75.55M | 80K 71.29K 66K 59.73K 113K 7.55M 114K 791K 311K 3.97M 300K 294K 12.64M |
Employees
-
